Palladium(II) and Nickel(II) Complexes of N,N,O-Chelate Ligands
[Li{2-[OC(Ph)2CH2]-6-(3,5-Me2C3HN2)C5H3N}] (2): A solution
49.05, 77.27, 113.98, 122.05, 122.38, 124.83, 125.14, 125.36, 126.40,
126.59, 126.87, 127.08, 128.08, 128.27, 128.88, 136.72, 137.72,
147.52, 155.62, 159.87 ppm. C31H29N3NiO (518.28): calcd. C 71.84,
H 5.64, N 8.11; found C 71.76, H 5.51, N 8.19. Single crystals of
complex 4a suitable for an X-ray diffraction analysis were obtained
by recrystallization of the sample from a mixture of thf and toluene.
of
2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyridine
(0.48 g,
2.57 mmol) in thf (10 mL) was cooled to about –60 °C and a solu-
tion of LDA in Et2O [prepared from diisopropylamine (0.29 g,
2.8 mmol) and nBuLi (1.2 mL of a 2.5 solution in hexane,
3 mmol) in Et2O] was added with stirring. After stirring at –20 °C
for 20 min, the mixture was added dropwise to a solution of benzo-
phenone (0.50 g, 2.75 mmol) in thf (5 mL) at about –80 °C. The
resultant mixture was warmed to room temperature and stirred for
12 h. The solvent was then removed under vacuum and the residue
dissolved in toluene (10 mL). The solution was filtered and the fil-
trate was concentrated to about 2 mL. Diethyl ether (2 mL) was
added to the solution to give compound 2 (0.54 g, 56%) as colorless
[Ni(1-C10H7){2-{OC(Ph)2CH2}-6-(3,5-Me2C3HN2)C5H3N}] (4b): A
solution of 2 (0.08 g, 0.21 mmol) in thf (5 mL) was added to a
stirred solution of [(Ph3P)2Ni(naphthyl)Br] (0.17 g, 0.22 mmol) in
thf (10 mL) at about –80 °C. The mixture was warmed to room
temperature and stirred for 30 h, then the solvent was removed un-
der vacuum and the residue extracted with CH2Cl2. The extract
was filtered and then concentrated to dryness to give a red solid,
which was recrystallized from a mixture of CH2Cl2/hexane (1:1) to
afford red crystals (0.11 g, 83%), m.p. 171–173 °C. 1H NMR
(CDCl3): δ = 0.72 (s, 3 H, Me), 2.32 (s, MeC6H5), 2.38 (s, 3 H,
Me), 3.54 (d, J = 15.3 Hz, 1 H, CH), 3.81 (d, J = 15.3 Hz, 1 H,
CH), 5.63 (s, 1 H, pyrazolyl), 6.90–6.98 (m, 4 H, Ar), 7.06–7.15 (m,
6 H, Ar), 7.20–7.31 (m, 5 H, Ar), 7.37 (d, J = 7.2 Hz, 3 H, Ar),
7.60 (d, J = 7.2 Hz, 3 H, Ar), 7.70 (t, J = 8.1 Hz, 1 H, Ar), 8.00
(d, J = 6.9 Hz, 1 H, Ar), 9.29–9.32 (m, 1 H, Ar) ppm. 13C NMR
(CDCl3): δ = 13.86, 21.58, 49.32, 77.27, 107.16, 114.41, 122.19,
122.74, 123.70, 123.79, 123.92, 125.08, 125.24, 125.43, 125.96,
126.72, 127.42, 127.61, 128.02, 128.36, 129.17, 132.75, 133.54,
133.89, 138.02, 139.14, 140.23, 141.68, 151.77, 151.82, 156.11,
156.97, 160.38 ppm. C34H29N3NiO·0.8C7H8 (628.02): calcd. C
75.73, H 5.68, N 6.69; found C 75.75, H 5.75, N 6.67.
1
crystals, m.p. 227–228 °C. H NMR (C6D6): δ = 1.79 (s, 3 H, Me),
2.20 (s, 3 H, Me), 3.86 (s, 2 H, CH2), 5.41 (s, 1 H, pyrazolyl), 6.12
(d, J = 8.1 Hz, 1 H, Py), 6.23 (d, J = 7.5 Hz, 1 H, Py) 6.68 (t, J =
7.8 Hz, 1 H, Py), 6.84–6.87 (m, 2 H, Ph), 6.98 (br., 4 H, Ph), 7.65
(d, J = 7.2 Hz, 4 H, Ph) ppm. 13C NMR (C6D6): δ = 13.03, 14.01,
53.27, 81.62, 109.45, 122.48, 124.31, 126.84, 137.06, 138.04, 148.64,
151.04, 162.25 ppm. C24H22LiN3O (375.39): calcd. C 76.79, H 5.91,
N 11.19; found C 76.90, H 5.90, N 11.11.
2-[OC(Ph)2CH2]-6-(3,5-Me2C3HN2)C5H3N (2Ј): Hydrochloric acid
(2 , 20 mL) was added to a solution of 2 [prepared from 1 (0.72 g,
3.85 mmol), LDA, and Ph2CO according to the above procedure]
in thf (15 mL). The mixture was stirred for 1 h and then neutralized
with 2 NaOH. The aqueous layer was extracted twice with
CH2Cl2 (20 mL each time), and the combined organic layers were
dried with MgSO4. After concentration in vacuo, the product was
recrystallized from CH2Cl2/Et2O to give a white solid (1.0 g, 70.4%
based on the amount of 1), m.p. 156–157 °C. 1H NMR (CDCl3): δ
= 2.28 (s, 3 H, Me), 2.43 (s, 3 H, Me), 3.74 (s, 2 H, CH2), 5.98 (s,
1 H, pyrazolyl), 6.91 (dd, J = 2.4, 6 Hz, 1 H, Py), 7.12–7.27 (m, 7
H, Ph), 7.41–7.44 7.12–7.27 (m, 3 H, Ph), 7.50–7.66 (m, 2 H, Py)
ppm. 13C NMR (CDCl3): δ = 13.70, 14.22, 47.50, 78.36, 109.33,
114.74, 122.11, 126.32, 126.78, 128.13, 139.28, 141.11, 146.89,
150.26, 152.30, 157.22 ppm. C24H23N3O (369.46): calcd. C 78.02,
H 6.27, N 11.37; found C 77.79, H 6.24, N 11.22.
2-[6-(3,5-Dimethyl-1H-pyrazol-1-yl)pyridin-2-yl]-1-phenylethanone
(5): A solution of 2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyr-
idine (0.48 g, 2.57 mmol) in thf (10 mL) was cooled to about –60 °C
and a solution of LDA in Et2O [prepared from diisopropylamine
(0.29 g, 2.8 mmol) and nBuLi (1.2 mL of a 2.5 solution in hexane,
3 mmol) in Et2O] was added with stirring. The mixture was stirred
at –20 °C for 20 min and was then added dropwise to PhCN
(0.30 g, 2.91 mmol) at about –80 °C. The resultant solution was
stirred at –20 °C for 30 min and at room temperature for 10 h. A
2 aqueous solution of H2SO4 (10 mL) was then added at 0 °C.
The mixture was stirred at room temperature for 10 h and then
neutralized with NaOH solution. The organic layer was separated
and the aqueous layer was extracted twice with diethyl ether
(20 mL each time). The combined ether solutions were dried with
Na2SO4, then the Na2SO4 was removed by filtration and the filtrate
was concentrated to give pale-yellow crystals (0.49 g, 66%), m.p.
[Pd(Cl){2-[OC(Ph)2CH2]-6-(3,5-Me2C3HN2)C5H3N}] (3): A solu-
tion of 2 (0.11 g, 0.29 mmol) in thf (5 mL) was added to a stirred
solution of [PdCl2(PhCN)2] (0.105 g, 0.27 mmol) in thf (10 mL) at
about –80 °C. The mixture was warmed to room temperature and
stirred for 10 h, then the solvent was removed under vacuum. The
residue was dissolved in CH2Cl2 and then filtered. Concentration
of the filtrate afforded pale-yellow crystals (0.11 g, 80%), m.p. 293–
295 °C. 1H NMR (CDCl3): δ = 2.54 (s, 3 H, Me), 2.59 (s, 3 H, Me),
1
80–81 °C. H NMR (CDCl3): δ = 2.19 (s, 3 H, Me), 2.41 (s, 3 H,
Me), 4.37 (s, 2 H, CH2), 5.86 (s, 1 H, pyrazolyl), 7.07 (t, J = 4.2 Hz,
3.97 (s, 2 H, CH2), 6.01 (s, 1 H, pyrazolyl), 7.03 (d, J = 7.8 Hz, 1 1 H, Ar), 7.32–7.50 (m, 3 H, Ar), 7.65 (d, J = 4.2 Hz, 2 H, Ar),
H, Py), 7.12–7.25 (m, 7 H, Ph+Py), 7.62 (d, J = 8.1 Hz, 4 H, Ph),
7.80 (t, J = 8.4 Hz, 1 H, Py) ppm. C24H22ClN3OPd (510.32): calcd.
C 56.49, H 4.35, N 8.23; found C 56.89, H 4.23, N 8.28.
7.94–7.97 (m, 2 H, Ar) ppm. 13C NMR (CDCl3): δ = 13.67, 14.64,
47.89, 109.05, 113.66, 120.71, 125.44, 128.43, 128.66, 128.85,
133.31, 136.59, 138.90, 141.68, 149.81, 153.28, 153.68, 196.73 ppm.
C18H17N3O (291.35): calcd. C 74.20, H 5.88, N 14.42; found C
74.28, H 5.58, N 14.26.
[Ni(o-MeC6H4){2-{OC(Ph)2CH2}-6-(3,5-Me2C3HN2)C5H3N}] (4a):
A solution of 2 (0.22 g, 0.59 mmol) in thf (5 mL) was added to a
stirred solution of [(Ph3P)2Ni(o-MeC6H4)Br] (0.44 g, 0.58 mmol) in
[Na{2-[OC(Ph)=CH]-6-(3,5-Me2C3HN2)C5H3N}] (6): A mixture of
thf (10 mL) at about –80 °C. The resultant solution was warmed 5 (0.60 g, 2.06 mmol) and NaH (0.08 g, 3.3 mmol) in thf (20 mL)
to room temperature and stirred for 30 h, then the solvent was re-
moved under vacuum and the residue was extracted with CH2Cl2.
The solvent was removed from the extract under reduced pressure
and the residual solid was recrystallized from thf to give red crystals
was refluxed for 12 h, then the mixture was filtered and the solvent
removed from the filtrate under vacuum. The residue was recrys-
tallized from a mixture of thf/hexane (1:1) to give pale-yellow crys-
tals (0.50 g, 77%), m.p. 245–247 °C. H NMR (C6D6): δ = 1.76 (s,
3 H, Me), 1.86 (s, 3 H, Me), 5.30 (s, 1 H, pyrazolyl), 5.67 (s, 1 H,
1
1
(0.28 g, 92%), m.p. 203–204 °C. H NMR (CDCl3): δ = 1.16 (s, 3
H, Me), 2.39 (s, 3 H, Me), 2.78 (s, 3 H, Me), 3.49 (d, J = 14.4 Hz,
CH), 5.92 (d, J = 7.5 Hz, 1 H, Py), 6.42–6.45 (m, 1 H, Py), 6.82–
1 H, CH), 3.68 (d, J = 14.4 Hz, 1 H, CH), 5.74 (s, 1 H, pyrazolyl), 7.16 (m, 4 H, Ph + Py), 7.99 (t, J = 7.8 Hz, 1 H, Py), 6.62–6.67
6.68–7.10 (m, 11 H, Ar), 7.37 (d, J = 6.3 Hz, 2 H, Ar), 7.61–7.70 (m, 4 H, Ph), 7.79 (d, J = 7.2 Hz, 2 H, Ph) ppm. 13C NMR (C6D6):
(m, 4 H, Ar) ppm. 13C NMR (CDCl3): δ = 13.50, 21.32, 24.97, δ = 13.57, 13.70, 95.16, 106.15, 108.68, 119.64, 127.02, 127.60,
Eur. J. Inorg. Chem. 2007, 4492–4499
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
4497